Acro Biomedical (ACBM) Cash from Operations (2015 - 2025)
Acro Biomedical (ACBM) posted Cash from Operations of -$25377.0 for Q4 2025, up 53.36% on a QoQ basis from -$54410.0 in Q3 2025, and down 141.34% year-over-year from $61384.7 in Q4 2024.
Powered by 
Analysis
Acro Biomedical (ACBM) Cash from Operations (2015 - 2025) Analysis & Trends
Acro Biomedical has reported Cash from Operations for 11 years, with the latest figure at -$25377.0 in Q4 2025.
- On a quarterly basis, Cash from Operations fell 141.34% year-over-year to -$25377.0 in Q4 2025; TTM through Dec 2025 was -$196302.0, a 435.0% decrease from a year earlier, with the FY2025 full-year figure at -$196302.0, down 435.0% from the prior year.
- Cash from Operations was -$25377.0 for Q4 2025 at Acro Biomedical, up from -$54410.0 in the prior quarter.
- The five-year high for Cash from Operations was $432770.0 in Q2 2021, with the low at -$345777.0 in Q2 2022.
- Average Cash from Operations over 5 years is -$4829.3, with a median of -$11590.5 recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 3228.07% in 2022, then plunged 1411.59% in 2024.
- Over 5 years, Cash from Operations stood at -$60506.0 in 2021, then surged by 82.53% to -$10568.0 in 2022, then decreased by 19.35% to -$12613.0 in 2023, then advanced by 16.63% to -$10515.0 in 2024, then sank by 141.34% to -$25377.0 in 2025.
- The last three Cash from Operations figures came in at -$25377.0 (Q4 2025), -$54410.0 (Q3 2025), and -$93984.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 995.00 Mn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 688.00 Mn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 908.00 Mn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 82.60 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 118.70 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 32.90 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -25,377.00 |
| Sep 30, 2025 | -54,410.00 |
| Jun 30, 2025 | -93,984.00 |
| Mar 31, 2025 | -22,531.00 |
| Dec 31, 2024 | -10,515.00 |
| Sep 30, 2024 | -6,335.00 |
| Jun 30, 2024 | -6,329.00 |
| Mar 31, 2024 | -13,513.00 |
| Dec 31, 2023 | -12,613.00 |
| Sep 30, 2023 | 483.00 |
| Jun 30, 2023 | 2,250.00 |
| Mar 31, 2023 | -5,566.00 |
| Dec 31, 2022 | -10,568.00 |
| Sep 30, 2022 | -53,268.00 |
| Jun 30, 2022 | -345,777.00 |
| Mar 31, 2022 | 262,132.00 |
| Dec 31, 2021 | -60,506.00 |
| Sep 30, 2021 | -64,549.00 |
| Jun 30, 2021 | 432,770.00 |
| Mar 31, 2021 | -8,380.00 |